MorphoSys AG
COMBINATIONS AND USES THEREOF
Last updated:
Abstract:
The present disclosure describes a pharmaceutical combination of an anti-CD19 antibody and a purine analog for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and/or acute lymphoblastic leukemia.
Status:
Application
Type:
Utility
Filling date:
3 Apr 2020
Issue date:
12 Nov 2020